Thompson Davis & Co »

Inmed Pharmaceuticals shares owned by Thompson Davis & Co

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Thompson Davis & Co from 13F filings

Historical chart of Thompson Davis & Co investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Thompson Davis & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Thompson Davis & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 10k 2.19

More positions owned by Thompson Davis & Co

Smith-Midland Corporation (SMID)
Carlisle Companies (CSL)
Dover Corporation (DOV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Sherwin-Williams Company (SHW)
Comfort Systems USA (FIX)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Specialized Funds Div App Etf (VIG)
Amazon (AMZN)
Chubb (CB)
Genedx Holdings Corp Com Cl A (WGS)
NVIDIA Corporation (NVDA)
Ge Vernova (GEV)
Costco Wholesale Corporation (COST)
Spdr Series Trust Portfolio Sh Tsr (SPTS)

View all positions for Thompson Davis & Co

Top funds holding Inmed Pharmaceuticals

Sabby Management
DRW Holdings
Virtu Financial
Renaissance Technologies
Thompson Davis & Co
SBI Securities
Banque Cantonale Vaudoise
Federation des caisses Desjardins du Quebec
AllSquare Wealth Management

View all funds holding Inmed Pharmaceuticals